Natural polyamine is an ideal antitumor drug carrier because of the great requirement difference between cancer cells and normal cells. Previous data demonstrated that many cytotoxic drugs conjugated with natural or synthetic polyamines have potent antitumor effects. Up to now, the antitumor mechanism of conjugates of naphthalimides with polyamine remains poorly understood in human colon cancer cells. The aim of this study is to evaluate the effect of MINS (a novel naphthalimide-polyamine conjugate) and mechanism of MINS in human colon cancer cells. Mitochondrial toxicity, which was generated by ROS from mitochondria electron transport chain, might be a major factor in MINS-inducted apoptosis. Our data also demonstrated that MINS-mediated cell apoptosis depend on p53 status, for MINS induced Caco-2 cells (p53 null) only necrosis but not apoptosis. Furthermore, the apoptotic effect of MINS is stronger than that of Amonafide, the parent drug of MINS. Our data suggested that the MINS-mediated cell apoptosis depend on p53 in human colon cancer cells.
cases diagnosed every year [1] . The structure of DNA in normal cells and tumor cells has many differences, so DNA become targets for anticancer drugs and DNA intercalating agents play an important role in antineoplastic chemotherapy [2] . Naphthalimide compounds as DNA intercalating agents exert potent antitumor effects in a variety of murine and human tumor cell lines [3] .
The natural polyamines, putrescine (Put), spermidine (Spd) and spermine (Spm), play an essential role in cellular growth and differentiation [4] [5] . The raised polyamine levels are closely linked with tumorigenesis. The polyamines induce the transformation from the normal cells to the malignant tumors by affecting cell proliferation and differentiation, and they also promote the development of tumors by promoting the synthesis of nucleic acids, some biological macromolecules and the formation of tumor blood vessels [6] .
Some polyamine analogues and conjugates exerted potent antitumor effects [7] . In recent years, we are committed to the researches of the synthesis and antitumor molecular mechanism of naphthalimide-polyamine conjugate. Most of the naphthalimide-polyamine conjugates exert potent antitumor effect via inducing apoptosis and/or autophagy [8] [9] . Up to now, the antitumor mechanism of conjugates of naphthalimides with polyamine remains poorly understood in human colon cancer cells. To explore the antitumor mechanism of conjugates of naphthalimides with polyamine in human colon cancer cells, we synthesized MINS, a novel naphthalimide-polyamine conjugate, in our laboratory and evaluated the apoptotic molecular mechanism in human colon cancer cells. Here, we first reported that apoptosis might be the terminal fate of human colon cancer cells treated with MINS. Mitochondrial toxicity, generated by ROS from mitochondria electron transport chain, might be a major factor in MINS-inducted apoptosis. Our data demonstrated that the MINS-mediated cell apoptosis depend on p53 condition, and the apoptotic effect of MINS is stronger than that of Amonafide which is the parent drug of MINS. Thus, MINS merits further investigation as a potential chemotherapeutic agent against colon cancers.
Materials and Methods

Materials
DMEM and fetal calf serum (FCS) were purchased from Gibco (Grand Island, NY, USA). McCoy's 5A, DMSO, Hoechst 33342, JC-1, rhodamine123 (Rh123), propidium iodide (PI) and 3-(4,5-dimethylthiazol)-2,5-diphenyltetrazolium bromide (MTT), pifithrin-α, reactive oxygen species (ROS) assay kit, Rotenone, Apocynin and n-acetyl-l-cysteine (NAC) were purchased from Sigma (St. Louis, MO, USA). Annexin V-FITC and Annexin V-PE apoptosis detection kit were purchased from Cell signaling Technology (Beverly, MA, USA). Z-DEVD-FMK, Z-IETD-FMK, Z-LEHD-FMK, and Primary antibodies: caspase-3, caspase-8, caspase-9, β-Actin, HSP60, Bcl-2, Bax, cytochrome c, p53, p21, as well as horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA, USA). All other chemicals used in the experiments were commercial products of reagent grade. MINS (purity: 99.2%) was synthesized in our laboratory and the structure formula was shown in Figure 1 (A).
Amplification and Extraction of pEGFP-N1-p53 Plasmid and Cell Transfection
Recombinant pEGFP-N1-p53 plasmids were purchased from Promega Beijing Biotech Co., Ltd (Beijing, China) and grown in Escherichia coli. After abundant amplification, the plasmid was purified using a plasmid extraction kit (Axygen Biosciences, CA, USA) and was suspended in 2.5 mM Tris-HCl (pH 8.5) at a concentration of 1.0 μg/μL. For transfection, Caco-2 cells were seeded in 6-well plates and incubated at 37˚C in a humidified incubator containing 5% CO 2 . The next day, when these cells were about 80% confluence, cells were transfected with Transfection Reagent according to the manufacturer's instructions. Briefly, DNA (1.0 μg) and 3.0 μl of GenJet Ver. II reagents (SignaGen, MD, USA) were diluted with serum free DMEM, respectively, and then the diluted GenJet Ver.II reagents were added to the diluted DNA and the formed transfection complex was kept at RT for 15 minutes. These transfected cells were selected with 0.1 mg/mL G418 for 8 weeks, and then the stable plasmid-transfected Caco-2-p53 cells were confirmed by RT-PCR and Western Blot (Supplementary Figure  2(A) and Supplementary Figure 2(B) ).
Cell Culture and Treatment
HT-29 cell line, HCT-116 cell line and Caco-2 (p53 null) cell line were purchased from Shanghai Institute for Biological Science, Chinese Academy of Sciences (Shanghai, China). Caco-2 cells, Caco-2-p53 cells with stably transfected p53, and HCT-116 cells were cultured in DMEM supplemented with 10% FCS (McCoy's 5A for HT-29 cells). 1 mM aminoguanidine was added as an inhibitor of amine oxidase derived from FCS and had no effect on the various parameters of the cells measured in this study [8] .
Antiproliferative Assay
The antiproliferative effect of MINS was evaluated in HT-29 cells, HCT-116 cells, Caco-2 (p53 null) cells and Caco-2-p53 cells by the conversion of MTT to a purple formazan precipitate [8] . Briefly, cells were seeded into 96-well plates at 5 × 10 3 cells/well. After 24 h, various concentrations of MINS were subsequently added and incubated for 48 h. The inhibitive rate was calculated from plotted results using untreated cells as 100%.
Cell Apoptosis Evaluation
Cell apoptosis was evaluated in HT-29 cells, HCT-116 cells, Caco-2 (p53 null) cells and Caco-2-p53 cells by high content screening (HCS) (Thermo Scientific Cellomics ArrayScan Vti, Cellomics, Inc., Pittsburgh, PA) analysis. Firstly, cells were seeded into 96-well plates at 5 × 10 4 cells/well. After 24 h, HT-29 cells were treated with MINS for 24 h, 36 h or 48 h. Then the cells were centrifugated with horizontal centrifuge for 5 min, stained with propidium iodide (50 μg/mL) in the dark for 60 min at 4˚C and washed 3 times with phosphate-buffered saline (PBS). Secondly, cells were stained with Annexin V-FITC in the dark for 15 min at room temperature, then washed 2 times with Annexin V-FITC binding solution. Briefly, Annexin V-FITC stock solution (1 μL) was added to Annexin V-FITC binding solution (20 μL) . Thirdly, cells were stained with Hoechst 33342 (10 µg/mL) in the dark for 15 min at room temperature, and washed 3 times with PBS. Finally, 50 μL PBS was added in every well. The analysis was done using Thermo Scientific Cellomics ArrayScan Vti (MA, USA). Because Caco-2-p53 cells in this study had been transfected green flourescence, so we used AnnexinV-PE with red fluorescene and PI, respectively. The experimental procedures referred to the above three staining methods. Annexin V-positive cells with nuclear shrinkage, blebbing, and apoptotic bodies were counted as apoptotic. The percentage of apoptotic cells was calculated after observing a total of 300 cells. For the p53 inhibitor analysis, the cells were pretreated with PFT-α (10 µM) for 2 h respectively, and then exposed with MINS.
Caspase Activity Assay
The activity of caspases was detected as our previous description [10] . Briefly, the cells, after treatment with MINS for 12 h, were harvested and lysed and then the cytosolic fraction was obtained by centrifugation at 12 000 × g at 4˚C for 20 min. DEVDase, IETDase, and LEHDase activities were evaluated by measuring proteo-lytic cleavage of chromogenic substrates Ac-DEVD-pNA, Ac-IETD-pNA, and Ac-LEHDpNA, which were used as the substrates for caspase-3, caspase-8, and caspase-9-like proteases, respectively. Briefly, the cell lysate (50 mg of protein) was added into the buffer containing 150 mol/L Ac-DEVD-pNA, Ac-IETD-pNA, and Ac-LEHD-pNA to a final volume of 150 µL. The reaction mixture was incubated at 37˚C for 1 h. The absorbance of enzymatically-released pNA was measured at 405 nm on a microplate reader every 20 min. For the caspase inhibitor analysis, the cells were pretreated with Z-DEVD-FMK (20 µM), Z-IEFD-FMK (20 µM) or Z-LEHD-FMK (20 µM) for 2 h respectively, and then exposed with MINS for 12 h.
Mitochondrial Membrane Potential Assay
Mitochondrial membrane potential (MMP) was assessed by the retention of Rh123 (JC-1 for Caco-2-p53 cells), a membrane-permeable fluorescent cationic dye. The uptake of Rh123 by mitochondria is proportional to the MMP. Briefly, cells harvested as above described were incubated with 20 μM Rh123 in the dark for 30 min at room temperature. After washing 3 times with PBS, the cells were stained with Hoechst 33342 and then analyzed by HCS [8] .
Reactive Oxygen Species Assay
Reactive oxygen specise (ROS) was assessed by ROS assay kit which detect ROS with fluorescent probe DCFH-DA (dihydroethidium for Caco-2-p53 cells). The cells harvested as above described were stained with 10 μM DCFH-DA in the dark for 15 min at room temperature. After washing 3 times with PBS, the cells were stained with Hoechst 33342 and then analyzed by HCS. For the ROS inhibitor analysis, the cells were pretreated with Rotenone (25 nM), Apocynin (100 µM) or NAC (500 µM) for 1 h respectively, and then exposed with MINS for 24 h [8] .
Western Blot
HT-29 cells, HCT-116 cells and Caco-2-p53 cells, treated with MINS for a specific time period, were harvested and washed with PBS. Total cellular protein was isolated using the protein extraction buffer (containing 150 mM NaCl, 10 mM Tris (pH 7.2), 5 mM EDTA, 0.1% Triton X-100, 5% glycerol and 2% SDS). Protein concentrations were determined using the protein assay kit. Cytosolic and mitochondrial fractions were separated by Kit (C3601, Beyotime, Nantong, China) as instruction. Equal amounts of proteins (50 μg/lane) were separated using 8% or 12% SDS-PAGE and transferred to PVDF membranes. The membranes were incubated with primary antibodies. After washed with PBS, the membranes were incubated with peroxidase-conjugated goat antimouse or antirabbit secondary antibody, followed by enhanced chemiluminescence staining through the enhanced chemiluminescence system. β-Actin (43 kDa) and HSP60 (60 kDa) were used to normalize for protein loading [8] .
Data Analysis
All data were presented as mean ± SD and analyzed using Students t test or analysis of variance (ANOVA) followed by q test.
Results
MINS Inhibited the Growth of Human Colon Cancer Cells
MINS inhibited the growth in a dose-and time-dependent manner in HT-29 cells, Caco-2-p53 cells and HCT-116 cells (Figure 1) . Amonafide, from which the MINS is derived, had inferior growth-inhibited effects in all three cell lines comparing with MINS. However, MINS had no obvious inhibition on the growth of p53-null cells (Caco-2) at same doses and times, even at 50 μM for 48 h treatment.
Apoptosis Induced by MINS in Three Human Colon Cancer Cells
Compared with control cells, the percentage of annexin V-positive cells was significantly increased after treatment with MINS in HT-29 cells, Caco-2-p53 cells and HCT-116 cells. Furthermore, the apoptotic rate was also increased in a time-and dose-dependence manner (Figure 2) , suggesting that MINS could induce apoptosis in three human colon cancer cells. To elucidate the molecular mechanism in MINS-mediated cell apoptosis, we first detected the activity of caspase-3, caspase-8 and caspase-9. After treatment with MINS, caspase-3, caspase-8 and caspase-9 were activated in HT-29 cells and Caco-2-p53 cells, however, only caspase-3 and caspase-9 were activated in HCT-116 cells (Figure 3) . Moreover, Z-DEVD-FMK, Z-IEFD-FMK or Z-LEHD-FMK could inhibit the activation of caspase-3, caspase-8, caspase-9 and cells apoptosis, respectively (Supplementary Figure 1(A) and Supplementary Figure 1(B) ), suggesting MINS-mediated cells apoptosis via death receptor pathway and mitochondrial apoptotic pathway in HT-29 cells and Caco-2-p53 cells, and only mitochondrial apoptotic pathway in HCT-116 cells, and the apoptosis was caspase dependent. The MMP of HT-29 cells, Caco-2-p53 cells and HCT-116 cells were decreased significantly after treatment with MINS (Figure 4) , and accordingly facilitated cytochrome c release from mitochondria to cytoplasm, respectively ( Figure 5) . Furthermore, the protein expression of Bax, p53 and p21 was up-regulated and Bcl-2 was down-regulated after treatment with MINS ( Figure 5) . MINS induced Caco-2 (p53 null) cells necrosis significantly compared with control, while no obvious apoptosis was observed after treatment with potent antiproliferative concentrations (100 μM and 200 μM) (Supplementary Figure 2(C) and Supplementary Figure 2(D) ), suggesting that the presence of p53 could influence the MINS-mediated cell death profile.
ROS and p53 Are Necessary for MINS-Induced Cell Apoptosis
Compared with control cells, ROS generation was significantly increased after treatment with MINS in HT-29 cells, Caco-2-p53 cells and HCT-116 cells (Figure 6) . NAC, an inhibitor of ROS, not only inhibited MINSmediated ROS generation but also attenuated MINS-induced growth inhibition, cell apoptosis, caspase-3 activation, p53, p21 and Bax up-regulation, and Bcl-2 down-regulation (Figure 7) . To further confirm the resource of MINS-mediated ROS, Rotenone and Apocynin, an inhibitor for mitochondria ROS and NADPH oxidase respectively, were respectively pre-incubated before MINS treatment. Rotenone significantly decreased MINS-mediated ROS generation, however, Apocynin only partly attenuated this effect, suggesting that mitochondria was the predominant resource in MINS-mediated ROS generation (Supplementary Figure 1(C) ).
To confirm the significance of p53, PTF-a, a specific p53 inhibitor, was used to detect the change of MINSinduced cell apoptosis. After pre-treatment with PTF-α, MINS-induced growth inhibition, cell apoptosis, caspase-3 activation, p53, p21 and Bax up-regulation and Bcl-2 down-regulation were obviously attenuated in HT-29 cells, Caco-2-p53 cells and HCT-116 cells (Figure 7) . Interestingly, co-preincubation of NAC and PTF-a almost completely reversed MINS-mediated cell apoptosis (Supplementary Figure 1(B) ). Furthermore, MINS 
Discussion
The occurrence and development of malignant tumor are closely related to the disorders of the intracellular polyamine homeostasis, furthermore, polyamine synthase activity and polyamine concentrations often prodigiously increased in tumor cells [5] [11] . Naphthalimide compounds, as DNA intercalating agents, had potential antitumor effects. Therefore, naphthalimide-polyamine conjugates have become one of the research focuses as antitumor drugs at present. In recent years, our laboratory is committed to the synthesis and evaluation of novel naphthalimide-polyamine conjugates as antitumor leading compounds. Some of them exert potent activity on K562 cells, MDA-MB-231 cells, HepG2 cells, BEL-7402 cells and other tumor cells than Amonafide, and also have favorable selectivity in vitro [12] [13] . NNINspm has the satisfactory identification ability about the polyamine transporter and favorable tumor targeting. Regrettably, NNINspm had obvious toxicity in therapeutic dose after evaluation in vivo [14] . So we made a further structural modification and a serial of novel naphthalimide-polyamine conjugates were synthesized. After initial screening, we found MINS exerted potent antiproliferative activity on many cancer cell lines and favourable selectivity between colorectal cancer cells and normal intestinal epithelial IEC-6 cells (data not shown). In addition, the antitumor mechanism of such compounds is infrequent in colorectal cancer. Accordingly, we elucidated the antiproliferative effects and the molecular mechanism of MINS in human colorectal cancer cell lines.
Previous data demonstrated that 5d, a naphthalimide-polyamine conjugate, induced murine melanoma B16 cell apoptosis via mitochondrial pathway and death receptor pathway [13] . NPC-16, another naphthalimide-polyamine conjugate, could induce HepG2 cells apoptosis and autophagy [8] . However, MINS only induced HCT-116 cells, HT-29 cells and Caco-2-p53 cells apoptosis but not autophagy (data not shown). Further, MINS induced apoptosis via mitochondrial pathway and death receptor pathway in HT-29 cells and Caco-2-p53 cells, but only mitochondrial pathway in HCT-116 cells and the apoptosis is caspase dependent. These findings suggested that naphthalimide-polyamine conjugates mediated apoptotic mechanism depend on cell types and the structural modification could change the cell death mode. Bcl-2 family members usually regulate mitochondrial apoptosis pathway [15] . In three colorectal cancer cells, MINS induced Bcl-2 down-regulation and Bax up-regulation, suggesting that Bcl-2 family members were involved in MINS-mediated cell apoptosis. Consequently, MINS induced MMP decrease and cytochrome c release from mitochondria to cytoplasm.
The generation of ROS in tumor cells, especially in the key parts of the cells, such as the cell membrane, mitochondrial membrane and the nucleus, can change the cellular redox state of equilibrium, start intracellular signal transduction, affect the proliferation of cells, and also regulate many apoptotic relative molecules, such as Bax, Caspase-3 and Caspase-8 [16] . This apoptotic effect is similar with 7c, an Amonafide analogue, which induced human Hela cervix carcinoma cell apoptosis via enhancement ROS generation [17] . Our results demonstrated that NAC not only reversed the apoptotic effects of MINS but also some apoptotic relative proteins. In addition, we also elucidated that the source of MINS-mediated ROS was predominantly due to the mitochondria electron transport chain. In addition, we previously also found that mononaphthalimide-spermidine conjugate could induce ROS accumulation and then lead to Hela cell apoptosis [18] . Therefore, ROS generation may be the common mechanism in naphthalimide derivates-mediated tumor cell apoptosis.
The p53 is involved in the apoptosis progress regulation through the causation of the cell cycle arrest and the regulation of Bcl-2 family [19] . The p21 is a Cyclin-dependent kinase inhibitor encoded by p53 downstream genes [20] . Our results demonstrated that MINS induced the up-regulation of p53 in three colorectal cancer cells in a time-and dose-dependent manner. Furthermore, pretreatment with pifithrin-α could attenuate MINS-mediated p53 up-regulation, and also regulate their downstream proteins, such as p21, Bcl-2 and Bax, suggesting that MINS-mediated apoptosis was dependent on p53 signal pathway. In addition, after treatment with effective concentrations which exerted antiproliferative activity, MINS only induced Caco-2 (p53 null) cells necrosis, but not apoptosis. Furthermore, MINS failed to induce significantly ROS production, suggesting that MINS-mediated apoptosis was dependent on p53.
Conclusion
In summary, MINS-induced cell apoptosis was associated with p53, ROS and Bcl-2 family members were also involved in this apoptotic process in HCT-116, HT-29, Caco-2-p53 human colon cancer cells. These results suggested that MINS merited further investigation and showed the therapeutic value in the treatment of cancers depending on p53 signaling pathway.
